Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 520-527

  Chapman, David E ^a   Hanson, Glen R ^a   Kesner, Raymond P ^b   Keefe, Kristen A ^a,c  

^a 301 Skaggs Hall   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Department of Pharmacology and Toxicology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MESSENGER RNA; METHAMPHETAMINE; NEUROMEDIN N; NEUROTENSIN; PREPRODYNORPHIN; PREPROENKEPHALIN; PREPROTACHYKININ; PSYCHOSTIMULANT AGENT; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ENZYME ACTIVITY; GLOBUS PALLIDUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEARNING TEST; MALE; MAZE TEST; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; METHAMPHETAMINE; NEURAL PATHWAYS; NEUROPEPTIDES; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SERIAL LEARNING; SUBSTANCE P; SUBSTANTIA NIGRA;

EID: 0035142834     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats
2. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin, and prodynorphin messenger RNA levels
3. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites
4. Molecular cloning and expression of the gene for a human D1 dopamine receptor
5. Long-term cognitive impairment in MPTP-treated rhesus monkeys
6. Behavioral indices of a moderate nigro-striatal 6-hydroxydopamine lesion: A preclinical Parkinson's model
7. D1 and D2 dopamine recepter-regulated gene expression of striatonigral and striatopallidal neurons
8. D1 and D2 dopamine receptor function in the striatum: Co-activation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons
9. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis
10. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: Role of the serotonin 2A/2C receptor
11. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway
12. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents
13. p53-Knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies
14. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain
15. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
16. Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: Evidence for involvement of pharmacologically distinct NMDA receptors?
17. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: Differential regulation and independence from NMDA receptors
18. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat
19. Nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner
20. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion
21. Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression
22. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse
23. Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors
24. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion
25. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
26. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task
27. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms
28. Cognitive deficits precede motor deficits in a slowly progressing model of Parkinsonism in the monkey
29. Dopamine D2 receptor dissociation constant for spiperone: Identical values using 3H-labeled agonist or 3H-labeled antagonist
30. Treatment of mice with methamphetamine produces cell loss in the substantia nigra
31. The topographical distribution of serotonergic terminals in the rat and caudate nucleus of the cat
32. Metabolic activity of the basal ganglia in Parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study
33. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA
34. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine
35. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission
36. Motor impairments after methamphetamine-induced neurotoxicity in the rat
37. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
38. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry
39. Brain cytochrome oxidase: Functional significance and bigenomic regulation in the CNS
40. Long-term effects of chronic methamphetamine administration in rhesus monkeys